tm logo
CAMKARM
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 06 Feb 2024

Last Applicant/ Owned by

Astraallén

Södertälje

SE

SE-15185

Serial Number

97723642 filed on 19th Dec 2022

Registration Number

N/A

Correspondent Address

Cara M. Kearney

ASTRAZENECA PHARMACEUTICALS LP

1800 CONCORD PIKE, A2C

WILMINGTON, DE 19850-5437

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CAMKARM

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases andRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Mark Details


Serial Number

No 97723642

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 104113/US

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Feb 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12th Dec 2023PUBLISHED FOR OPPOSITION
12th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07th Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
06th Nov 2023ASSIGNED TO LIE
06th Nov 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
06th Nov 2023TEAS/EMAIL CORRESPONDENCE ENTERED
02th Jun 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
10th Mar 2023NON-FINAL ACTION WRITTEN